Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Madhavbaug Begins the New Year on a Positive and Healthy Note by Helping 800 Diabetic Patients Reverse their condition in the Pandemic Era

Madhavbaug Logo (PRNewsfoto/Madhavbaug)

News provided by

Madhavbaug

12 Jan, 2021, 08:00 IST

Share this article

Share toX

Share this article

Share toX

MUMBAI, Jan. 12, 2021 /PRNewswire/ -- 2020 was a tough year for every nation and every individual around the world. It was full of fear, uncertainty and distress. The mere thought of losing a loved one was just too much to fathom. Everybody - the young, the old, the rich, the poor - craved some positivity and prayed that the new year began on a positive note. Madhavbaug brings a sliver of positivity in the midst of fear and stress. As the new year begins, Madhavbaug is proud to announce that 800 diabetic patients could successfully reverse their condition under its care.   

The Journey

Continue Reading
Victorious Patients Conquering Type 2 Diabetes
Victorious Patients Conquering Type 2 Diabetes

As the COVID-19 pandemic brought the world down to its knees, it was difficult to move around. As patients were limited to the confines of their homes and nothing was certain, the unpredictable nature of the disease gave rise to distress and created panic in people, especially the senior citizens who had an underlying disease, more so in those with diabetes. Experts around the world treating the affected individuals found that over 48% of the patients who lost their lives had underlying comorbidities. Out of that 48%, the majority were diabetic. In India too the numbers were concerning. About 39.7% of people who died of COVID-19 were found to have diabetes. 

These figures and data caused great concern to the team at Madhavbaug. They had to reach out to all their patients without exposing them to the virus, which was a tough task. There was no viable solution in sight. This is when Chief Medical Officer, Dr. Gurudatta Amin took control. Under his guidance and after some brainstorming, the team came up with the idea of guiding the house-bound patients online. This laid the foundation of the user-friendly and extremely easy to use health app -  MiBPulse. However, the bigger challenge was to take the in-clinic program, that Madhavbaug has been running for 14 years, online. The team of doctors at Madhavbaug worked around the clock to help the patients, and their hard work paid off. The results were absolutely astounding! Not a couple, but 800 patients conquered their diabetes and minimized the risk of falling prey to COVID-19.    

MiBPulse app is a simple chat-based application that enables the users to connect with Madhavbaug's experts and help them find solutions to their health problems. Initially, the app had about ten thousand subscribers, but just within a month, the number swelled to fifty thousand. With the help of the app, the doctors could guide patients in terms of lifestyle changes, exercise routine, diet plans, and several other factors to help them manage their conditions.

The app is loaded with features that help doctors and patients connect easily. With the app, patients can communicate with the doctors directly via the chat feature. Madhavbaug's 200+ doctors are listed in the app with whom the patients can connect at any hour. The brilliant use of technology and the dedication of the doctors at Madhavbaug are the biggest contributing factors that have enabled them to get such amazing results in terms of diabetes reversal, during the COVID-19 era.

Sharing his thoughts on the victory, Operations Head of Madhavbaug, Dr. Pravin Ghadigaonkar quoted, "We advised each of our patients to look at this catastrophe not as a problem but as a golden opportunity. We explained to them that instead of stressing over rumors and fake news, they should use this time to improve their health. We guided them as to how they could use this time to improve their health. We instilled positivity in their minds, as we believe that a happy mind makes a healthy body. This approach brought exciting results, which you can see. We could help people suffering from diabetes, hypertension and heart diseases conquer their ailments and get healthy even during a pandemic."

Every year, Madhavbaug celebrates the success of its patients who conquer their health conditions. However, with the pandemic restrictions, it wasn't possible to host a grand event like they usually do. Therefore, this time they hosted the Victory Function online.

Explaining the essence of the function, Dr. Ghadigaonkar, who has been a part of patient care at Madhavbaug for the past 12 years further said, "For the past 3 years we at Madhavbaug celebrate a Victory Function. This is for the patients who successfully conquer their diabetes. After undergoing the Ayurvedic Panchakarma treatment the patients have to take a G.T.T test and do not consume any medications for two months. If the test results are successful and the patients do not need any medication, is when we can say that they have finally driven out diabetes from their bodies. These patients are then invited to the function and are felicitated with a certificate of honor or citation."

CEO and Founder of Madhavbaug, on the occasion, quoted, "the basic objective of celebrating the Victory Function is to create awareness among the growing number of diabetic patients because it is now proved that the type 2 diabetes is completely reversible, and the patients do not need to spend the rest of their lives using medication and insulin or following a certain diet. Bringing patients who have successfully conquered diabetes and have them narrate their experience to the others who are still suffering from the condition, can motivate them to undergo the treatment and live a healthy and free life."

Madhavbaug believes in evidence-based practice. Their research papers that contain valuable scientific evidence have already been published in various national and international journals. The International Journal of Innovative Research in Medical Sciences, International Journal of Diabetes and Endocrinology, European Journal of Biomedical and Pharmaceutical Sciences, and the European Journal of Pharmaceutical and Medical Research are a few of the many renowned publications that have featured their work.

Getting 800 people to reverse their diabetes during a pandemic, is commendable. The success was possible because Madhavbaug and its team stood firmly with their patients. The doctors guided each patient throughout their treatment. With such astounding successes, Madhavbaug's goal of making India a diabetes-free country is not too far.

Photo: https://mma.prnewswire.com/media/1417829/Madhavbaug_Victorious_Patients.jpg 
Logo: https://mma.prnewswire.com/media/1141596/Madhavbaug_Logo.jpg 

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.